SSNA1 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the SSNA1 protein (also known as small nuclear RNA activating protein 1), which plays a significant role in various cellular processes, including the organization of the cytoskeleton and the regulation of microtubule dynamics. SSNA1 is involved in the stabilization of microtubules, which are essential components of the cell's structural framework and are crucial for processes such as cell division, intracellular transport, and the maintenance of cell shape. By binding to microtubules, SSNA1 influences their assembly and stability, thereby affecting the overall dynamics of the cytoskeleton. Inhibition of SSNA1 disrupts these interactions, leading to alterations in microtubule organization and, consequently, in cellular functions dependent on the cytoskeleton.
The chemical structure of SSNA1 inhibitors is designed to specifically interfere with the protein's ability to bind to microtubules or its interactions with other cytoskeletal components. These inhibitors may act by binding directly to SSNA1, blocking its interaction sites, or by inducing conformational changes that prevent it from associating with microtubules. The development of SSNA1 inhibitors often involves a detailed understanding of the protein's structure, particularly its binding domains and the molecular mechanisms by which it interacts with microtubules. By targeting these critical regions, SSNA1 inhibitors can selectively modulate the protein's function without affecting other proteins involved in cytoskeletal regulation. This specificity is important for dissecting the role of SSNA1 in cytoskeletal dynamics and understanding how it contributes to broader cellular processes. Researchers utilize these inhibitors to study the effects of SSNA1 on microtubule stability, cell division, and other cytoskeleton-related activities, providing valuable insights into the molecular underpinnings of cellular organization and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol is a mitotic inhibitor. It stabilizes microtubules and prevents depolymerization, which can indirectly affect SSNA1's role in cell cycle control. | ||||||
Vinblastine Sulfate | 143-67-9 | sc-201447 sc-201447A sc-201447B sc-201447C | 10 mg 50 mg 100 mg 1 g | $109.00 $412.00 $561.00 $2244.00 | 9 | |
Vinblastine is a vinca alkaloid that inhibits microtubule formation. It can indirectly influence SSNA1 by altering the cell cycle dynamics. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine inhibits microtubule polymerization. By doing so, it can indirectly affect SSNA1's cell cycle-related functions. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Bleomycin is a glycopeptide antibiotic. It causes DNA breaks, potentially affecting apoptotic pathways associated with SSNA1. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin is an anthracycline antibiotic that intercalates DNA, inhibiting topoisomerase II and disrupting DNA repair, which may indirectly involve SSNA1. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide is a semisynthetic derivative of podophyllotoxin that inhibits DNA topoisomerase II, which could indirectly influence SSNA1's involvement in apoptosis. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin causes DNA damage, potentially impacting the cell cycle and apoptotic pathways associated with SSNA1. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate is a folate analog that inhibits dihydrofolate reductase (DHFR), affecting DNA synthesis and cell proliferation, which may indirectly impact SSNA1. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil is a pyrimidine analog that inhibits thymidylate synthase, disrupting DNA synthesis and cell proliferation, potentially affecting SSNA1 indirectly. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin is a cytotoxic quinoline alkaloid which inhibits the DNA enzyme topoisomerase I, potentially affecting the cell cycle and apoptotic pathways involving SSNA1. | ||||||